Suzano S.A. SUZB3

KMB's Arbex joint venture with Suzano sharpens its focus on global personal care as international markets post strong gains.

Suzano (NYSE:SUZ) reported second-quarter 2026 results marked by stronger free cash flow, higher pulp prices and improved paper sales volumes, while geopolitical volatility, inflation in oil-linked inputs and maintenance-related disruptions weighed on costs and operations. Chief Executive Officer B

SAO PAULO, August 12, 2026--Suzano, the world’s largest pulp producer, announces its results for the second quarter of 2026 (2Q26), reporting higher prices, stronger volumes and improvements in Adjusted EBITDA and operating cash generation compared to the previous quarter. The quarterly results reflect the competitiveness and resilience of Suzano’s operations in a quarter marked by foreign exchange headwinds and pressure on input costs driven by higher oil prices affecting the industry as a whol

Barrick Mining (B) delivered earnings and revenue surprises of +1.24% and +17.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Sylvamo (SLVM) delivered earnings and revenue surprises of +121.43% and +0.75%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Investors need to pay close attention to SUZ stock based on the movements in the options market lately.

Despite a 100 bps organic sales miss from China diaper issues and North America inventory cuts, KMB leveraged a $45M tariff refund and 6.4% productivity to deliver EPS ahead of guidance.

LONDON, July 01, 2026--Arbex, a new global leader in tissue and hygiene, today commences operations as an independent business and unveils details of its brand, leadership team, and company structure. Announced in June 2025 as a $3.4 billion joint venture between Suzano (NYSE: SUZ), the world’s largest pulp supplier, and Kimberly-Clark Corporation (NASDAQ: KMB), a global leader in consumer goods and personal care, the new business will manufacture, market and distribute consumer and professional

SUZ vs. KLBAY: Which Stock Is the Better Value Option?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

SUZ vs. KLBAY: Which Stock Is the Better Value Option?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Originally unveiled in June last year, the transaction will result in Suzano acquiring a controlling 51% interest in Kimberly-Clark’s international tissue operations.

Suzlon Energy’s fair value estimate has been nudged from ₹63.54 to ₹63.62, a very small change that still matters if you are tracking where analysts see the stock settling. This tweak sits alongside commentary that sentiment toward cyclical and commodity linked sectors can turn cautious quickly, which is feeding into how closely analysts are recalibrating their models. Read on to see how this evolving narrative might shape the way you monitor Suzlon Energy from here. Analyst Price Targets...

Kimberly-Clark (NasdaqGS:KMB) announced an agreement to acquire Kenvue, expanding its reach in consumer health brands. The company is realigning its joint venture with Suzano, which includes plans to divest lower-growth operations. Kimberly-Clark is launching Pull-Ups Learning Layer technology nationwide, targeting parents focused on potty training support. Kimberly-Clark, best known for tissues, diapers and personal care products, is using the Kenvue deal to lean further into branded...

Kimberly-Clark and Suzano's tissue joint venture received the expected unconditional antitrust approval from the European Union. Huggies launched its "Natural Born Fighters" social impact campaign focused on supporting babies in neonatal intensive care units and their families. For Kimberly-Clark (NasdaqGS:KMB), the fresh EU approval is a meaningful international step for its tissue partnership with Suzano, coming as the stock trades around $99.19. Over the past year, the share price shows...

The European Commission is anticipated to clear the deal following a preliminary review later this month, having found no competition concerns with the transaction.

Kimberly-Clark (NASDAQ:KMB) executives outlined the company’s ongoing strategic shift during a London fireside chat, highlighting efforts to drive volume-led growth under its “Powering Care” strategy, reduce earnings volatility through an international tissue joint venture with Suzano, and expand in